Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
224.94+8.42 (+3.89%)
At close: 04:00PM EST
224.50 -0.44 (-0.20%)
After hours: 07:59PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close216.52
Open218.88
Bid218.00 x 1100
Ask224.10 x 800
Day's Range218.37 - 225.38
52 Week Range173.45 - 371.16
Volume1,146,473
Avg. Volume1,209,463
Market Cap35.383B
Beta (5Y Monthly)1.13
PE Ratio (TTM)50.66
EPS (TTM)4.44
Earnings DateFeb 07, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est243.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-1% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ILMN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Illumina, Inc.
    Analyst Report: Illumina IncIllumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company's products and services are sold to genomic research centers, academic institutions, government and commercial laboratories, and hospitals, as well as to pharmaceutical, biotech, agrigenomics, and consumer genomics businesses. The company's portfolio of products and services are designed to accelerate and simplify genetic analysis. The company also invests in startup companies that are pursuing promising genomic-related opportunities. It has roughly 9,800 full-time employees. ILMN shares are included in the S&P 500 index.
    Rating
    Fair Value
    Economic Moat
    9 days agoArgus Research
View more
Advertisement
Advertisement